Ask Warren

Icure Pharmaceutical Incorporation

175250 · KOSDAQ · ₩175250 · 아이큐어

₩1,530▲ ₩159 (11.60%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy

Filings

  • Amended: Half-year report (Jun 2026)[기재정정]반기보고서 (2026.06)

    Predicted impact: Low

    Oct 20, 2026Open on DART
  • Amended: Half-year report (Jun 2026)[기재정정]반기보고서 (2026.06)

    Predicted impact: Low

    Oct 20, 2026Open on DART
  • Amended: 5%+ holding report[기재정정]주식등의대량보유상황보고서(일반)Oct 7, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Oct 7, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 30, 2026Open on DART
  • Amended: Half-year report (Jun 2026)[기재정정]반기보고서 (2026.06)Sep 18, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 15, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 10, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 9, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 9, 2026Open on DART
  • Change of largest shareholder최대주주변경을수반하는주식담보제공계약체결Sep 4, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 4, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Sep 4, 2026Open on DART
  • Other management matters기타경영사항(자율공시) (최대주주 보유주식의 자발적 의무보유 시행)Sep 3, 2026Open on DART
  • Amended: Change of largest shareholder[기재정정]최대주주변경Sep 3, 2026Open on DART
  • [Amended] Results of Securities Issuance (Voluntary Disclosure) (Third-Party Allotment Rights Offering)[기재정정]증권발행결과(자율공시) (제3자배정유상증자)Sep 3, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Sep 3, 2026Open on DART
  • Trading halt주권매매거래정지해제 (상장유지 결정)Sep 2, 2026Open on DART
  • Other Market Notice (Result of Listing Committee Deliberation and Resolution, and Notice of Continued Listing Decision)기타시장안내 (기업심사위원회 심의·의결 결과 및 상장유지 결정 안내)Sep 2, 2026Open on DART
  • Change of largest shareholder최대주주변경을수반하는주식담보제공계약해제ㆍ취소등Sep 1, 2026Open on DART
  • Amended: Change of largest shareholder[기재정정]최대주주변경Aug 31, 2026Open on DART
  • [Amended] Results of Securities Issuance (Voluntary Disclosure)[기재정정]증권발행결과(자율공시)Aug 31, 2026Open on DART
  • Market Notice (Mandatory Holding by Largest Shareholder)기타시장안내(최대주주의의무보유관련)Aug 28, 2026Open on DART
  • Change of largest shareholder최대주주변경Aug 28, 2026Open on DART
  • Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Aug 28, 2026Open on DART
  • Results of Extraordinary Shareholders' Meeting임시주주총회결과Aug 28, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Aug 28, 2026Open on DART
  • Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Aug 28, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Aug 28, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Aug 18, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Aug 14, 2026Open on DART
  • Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
  • Amended: Shareholders' meeting called[기재정정]주주총회소집결의Aug 13, 2026Open on DART
  • [Amended] Reference Document for Proxy Solicitation of Voting Rights[기재정정]의결권대리행사권유참고서류Aug 13, 2026Open on DART
  • Amended: Notice of shareholders' meeting[기재정정]주주총회소집공고Aug 13, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Aug 12, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Aug 5, 2026Open on DART
  • Other Market Notice (Submission of Details of Implementation of Improvement Plan)기타시장안내 (개선계획 이행내역서 제출)Aug 4, 2026Open on DART
  • [Amended] Reference Document for Proxy Solicitation of Voting Rights[기재정정]의결권대리행사권유참고서류Aug 4, 2026Open on DART
  • Amended: Notice of shareholders' meeting[기재정정]주주총회소집공고Aug 4, 2026Open on DART
  • Amended: Shareholders' meeting called[기재정정]주주총회소집결의Aug 3, 2026Open on DART
  • Lawsuit filed or ruled소송등의판결ㆍ결정 (직무집행정지가처분-취하)Jul 24, 2026Open on DART
  • Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Jul 22, 2026Open on DART
  • Notice of shareholders' meeting주주총회소집공고Jul 22, 2026Open on DART
  • Amended: Shareholders' meeting called[기재정정]주주총회소집결의 (임시주주총회)Jul 21, 2026Open on DART
  • Delisting기타시장안내 (개선기간 종료에 따른 상장폐지 여부 결정 안내)Jul 13, 2026Open on DART
  • [Amended] Disclosure Under Timely Disclosure Obligations (Fair Disclosure) (Termination of License Transfer Agreement for Donepezil Patch (Product Name: Donesive Patch))[기재정정]수시공시의무관련사항(공정공시) (도네페질 패치제 (제품명 : 도네시브 패치)의 라이센스 이전 계약해지)Jul 2, 2026Open on DART
  • [Amended] Disclosure Under Timely Disclosure Obligations (Fair Disclosure) (Termination of License Transfer Agreement for Donepezil Patch (Product Name: Donesive Patch))[기재정정]수시공시의무관련사항(공정공시) (도네페질 패치제 (제품명 : 도네시브 패치)의 라이센스 이전 계약해지)Jul 1, 2026Open on DART
  • Shareholders' meeting called주주총회소집결의 (임시주주총회)Jun 29, 2026Open on DART
  • Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Jun 29, 2026Open on DART

Titles in Korean until English translations are added.

Also known as: Icure Pharmaceutical Incorporation / 아이큐어 / 175250 / KRX:175250

Source: KRX statistical information